These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 14619822)

  • 1. Low-dose HRT may thwart bone loss. One form of low-dose HRT seems to preserve bone, but its safety remains uncertain.
    Runowicz CD
    Health News; 2003 Nov; 9(11):12-3. PubMed ID: 14619822
    [No Abstract]   [Full Text] [Related]  

  • 2. Low-dose estrogen therapy for prevention of osteoporosis: working our way back to monotherapy.
    Richman S; Edusa V; Fadiel A; Naftolin F
    Menopause; 2006; 13(1):148-55. PubMed ID: 16607111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postmenopausal osteoporosis and hormone replacement therapy.
    Gambacciani M; Vacca F
    Minerva Med; 2004 Dec; 95(6):507-20. PubMed ID: 15785435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low dose hormone replacement therapy: clinical efficacy.
    Mattsson LA; Sporrong T
    Minerva Ginecol; 2003 Jun; 55(3):201-7. PubMed ID: 14581865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
    Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M
    Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of postmenopausal bone loss with long-cycle hormone replacement therapy.
    Popp AW; Bodmer C; Senn C; Fuchs G; Kraenzlin ME; Wyss H; Birkhaeuser MH; Lippuner K
    Maturitas; 2006 Jan; 53(2):191-200. PubMed ID: 16368472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased coronary events, HERS, and HRT: any connection?
    Rebar RW; Archer D
    Arch Intern Med; 2001 May; 161(10):1350-1. PubMed ID: 11371266
    [No Abstract]   [Full Text] [Related]  

  • 8. A modern approach to postmenopausal HRT: trading bleeding with safety.
    Al-Azzawi F; Wahab M
    Womens Health (Lond); 2012 Jan; 8(1):1-4. PubMed ID: 22171766
    [No Abstract]   [Full Text] [Related]  

  • 9. Ultra low-dose hormone replacement therapy and bone protection in postmenopausal women.
    Gambacciani M; Cappagli B; Ciaponi M; Pepe A; Vacca F; Genazzani AR
    Maturitas; 2008 Jan; 59(1):2-6. PubMed ID: 18063490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Right or wrong of the hormone replacement therapy involving osteoporosis].
    Hoshino S; Ouchi Y
    Clin Calcium; 2004 Nov; 14(11):87-98. PubMed ID: 15577164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. By the way, doctor. I'm one year into menopause and really bothered by hot flashes and vaginal dryness. I'd like to take hormone replacement therapy, but I'm worried about increasing my risk of getting breast cancer. My doctor said I can take HRT at a dose longer than what's usually prescribed. What do you think?
    Robb-Nicholson C
    Harv Womens Health Watch; 2001 Sep; 9(1):7. PubMed ID: 11572838
    [No Abstract]   [Full Text] [Related]  

  • 12. Guidelines for hormone treatment of women in the menopausal transition and beyond.
    Naftolin F; Schneider HP; Sturdee DW;
    Maturitas; 2005 May; 51(1):15-20. PubMed ID: 15883104
    [No Abstract]   [Full Text] [Related]  

  • 13. Estrogen plus progestin, benefits and risks: the "Women's Health Initiative" trials.
    Keller KB; Lemberg L
    Am J Crit Care; 2005 Mar; 14(2):157-60. PubMed ID: 15728959
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hormone therapy and risk for venous thromboembolism in postmenopausal women].
    Lacut K; Oger E
    Rev Prat; 2005 Feb; 55(4):389-92. PubMed ID: 15828617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hormone replacement therapy and breast cancer risk in Kyushu University Hospital: supporting the Women's Health Initiative study.
    Nozaki M; Koera K; Nagata H; Nakano H
    J Obstet Gynaecol Res; 2004 Aug; 30(4):297-302. PubMed ID: 15238106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose estrogen for bone loss.
    Harv Womens Health Watch; 1998 May; 5(9):7. PubMed ID: 9589156
    [No Abstract]   [Full Text] [Related]  

  • 17. The oxidative metabolism of estrogen modulates response to ERT/HRT in postmenopausal women.
    Armamento-Villareal RC; Napoli N; Klug T; Civitelli R
    Bone; 2004 Sep; 35(3):682-8. PubMed ID: 15336604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of breast cancer with HRT depends on therapy type and duration.
    Saul H; Gursul D; Cassidy S; Vinogradova Y
    BMJ; 2022 Mar; 376():o485. PubMed ID: 35260385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the effects of raloxifene and low-dose hormone replacement therapy on bone mineral density and bone turnover in the treatment of postmenopausal osteoporosis.
    Dane C; Dane B; Cetin A; Erginbas M
    Gynecol Endocrinol; 2007 Jul; 23(7):398-403. PubMed ID: 17701771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lower doses of HRT protect bones.
    Health News; 2002 Jul; 8(7):7. PubMed ID: 12132506
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.